Development of censored data-based robust design for pharmaceutical quality by design
β Scribed by Byung Rae Cho; Yongsun Choi; Sangmun Shin
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 235 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0268-3768
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The development of a robust tablet formulation for a high dose active pharmaceutical ingredient (API) by the trial-and-error approach is challenging. To meet the growing needs of bringing drugs to market faster and with reduced costs, more targeted and efficient development practices are in demand.
Ammonio methacrylate copolymers are commercially available as Eudragit RL/RS; they differ in the degree of quaternary ammonium group substitution, which gives them different permeabilities. These closely related polymers can be combined in various ratios to control release rate; consequently, releas
In the course of our work aimed at developing novel heterocycles of pharmaceutical interest, we designed and synthesized several polycyclic templates as potential substrates to be used in drug design. We obtained a set of condensed ring systems as versatile structural platforms to generate potential